Price$23.43+1.00 (+4.48%)
01:30 PM07:45 PM
News · 26 weeks56-50%
2025-11-022026-04-26
Mix3990d
- Insider28(72%)
- SEC Filings4(10%)
- Other3(8%)
- Earnings3(8%)
- Analyst1(3%)
Latest news
25 items- SECSEC Form SCHEDULE 13G filed by Enovis CorporationSCHEDULE 13G - Enovis CORP (0001420800) (Subject)
- ANALYSTWilliam Blair resumed coverage on Enovis CorporationWilliam Blair resumed coverage of Enovis Corporation with a rating of Outperform
- INSIDERSEC Form 3 filed by new insider Singleton Laura Lee3 - Enovis CORP (0001420800) (Issuer)
- PREnovis to Host First Quarter 2026 Results Conference Call on May 7thDallas, TX, April 10, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE:ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its first quarter 2026 financial results on Thursday, May 7th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the "Investors" section of Enovis' website at www.enovis.com. Conference Call/Webcast Information Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-987
- SECSEC Form DEFA14A filed by Enovis CorporationDEFA14A - Enovis CORP (0001420800) (Filer)
- SECSEC Form DEF 14A filed by Enovis CorporationDEF 14A - Enovis CORP (0001420800) (Filer)
- INSIDERSEC Form 4 filed by Ortiz Christine4 - Enovis CORP (0001420800) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Enovis CorporationSCHEDULE 13G/A - Enovis CORP (0001420800) (Subject)
- INSIDERChief Administrative Officer Engert Oliver bought $23,740 worth of shares (1,000 units at $23.74), increasing direct ownership by 2% to 48,640 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERChief Administrative Officer Engert Oliver bought $23,930 worth of shares (1,000 units at $23.93), increasing direct ownership by 2% to 47,640 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSEC Form 4 filed by Enovis Corporation4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSEC Form 4 filed by Enovis Corporation4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSEC Form 4 filed by Enovis Corporation4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSVP, Chief Financial Officer Berry Phillip Benjamin (Ben) covered exercise/tax liability with 3,167 shares and was granted 47,974 shares, increasing direct ownership by 39% to 158,596 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERGROUP PRESIDENT, RECON Vogt Louis covered exercise/tax liability with 1,980 shares and was granted 36,247 shares, increasing direct ownership by 99% to 68,875 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERGROUP PRESIDENT, P&R Ross Terry D covered exercise/tax liability with 2,376 shares and was granted 36,247 shares, increasing direct ownership by 98% to 68,477 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSVP and Chief Legal Officer Tandy Bradley J covered exercise/tax liability with 1,874 shares and was granted 25,586 shares, increasing direct ownership by 57% to 65,641 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSEC Form 4 filed by Enovis Corporation4 - Enovis CORP (0001420800) (Issuer)
- INSIDERGROUP PRESIDENT, RECON Vogt Louis covered exercise/tax liability with 888 shares, decreasing direct ownership by 3% to 34,608 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERGROUP PRESIDENT, P&R Ross Terry D covered exercise/tax liability with 765 shares, decreasing direct ownership by 2% to 34,606 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSVP, Chief Financial Officer Berry Phillip Benjamin (Ben) covered exercise/tax liability with 2,220 shares, decreasing direct ownership by 2% to 113,789 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERPrincipal Accounting Officer Kleckner John covered exercise/tax liability with 442 shares, decreasing direct ownership by 4% to 11,545 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSVP and Chief Legal Officer Tandy Bradley J covered exercise/tax liability with 1,102 shares, decreasing direct ownership by 3% to 41,929 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERDirector Shirley Brady covered exercise/tax liability with 3,059 shares, decreasing direct ownership by 3% to 101,243 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
- INSIDERSVP, Chief HR Officer Lang Patricia A covered exercise/tax liability with 1,173 shares, decreasing direct ownership by 2% to 53,086 units (SEC Form 4)4 - Enovis CORP (0001420800) (Issuer)
ENOV FAQ
6 questionsWhat does Enovis Corporation do?
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular...Where does ENOV stock trade?
Enovis Corporation (ENOV) is listed on NYSE.What sector and industry is ENOV in?
Enovis Corporation operates in the Health Care sector, Industrial Specialties industry.What are analysts saying about ENOV?
Enovis Corporation has had 8 recent analyst actions on file. The most recent action was from William Blair: Outperform on 2026-04-17. Recent price targets cluster around $4100.00.What companies are similar to ENOV?
Notable peers in the same industry include ISRG (Intuitive Surgical Inc.), EW (Edwards Lifesciences Corporation), STE (STERIS plc (Ireland)), ZBH (Zimmer Biomet Holdings Inc.), MAS (Masco Corporation). Compare ENOV side-by-side with any of them on Quantisnow.How can I track ENOV on Quantisnow?
Quantisnow aggregates Enovis Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ENOV to receive live email and push alerts on every new disclosure.